26 October 2015 - Deborah Wilkes
Archived
Perrigo plans to divest its vitamins, minerals and supplements (VMS) business in the US as part of a package of initiatives designed to "drive substantial profit growth in 2016 and beyond". Chairman and chief executive officer Joseph Papa said the move made "the gross inadequacy of Mylan's offer clearer than ever".
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.